Adaptive Biotechnologies Corporation (MUN:1HM)
Germany · Delayed Price · Currency is EUR 13.04
+1.11 (9.35%)
Last updated: Nov 20, 2025, 8:01 AM CET
Adaptive Biotechnologies Market Cap
Adaptive Biotechnologies has a market cap or net worth of €2.47 billion as of November 21, 2025. Its market cap has increased by 212.68% in one year.
Market Cap
2.47B
Enterprise Value
2.47B
Revenue
215.42M
Ranking
n/a
PE Ratio
n/a
Stock Price
€13.04
Market Cap Chart
Since June 27, 2019, Adaptive Biotechnologies's market cap has decreased from 4.20B to 2.47B, a decrease of -41.18%. That is a compound annual growth rate of -7.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 2.47B | 189.11% |
| Dec 31, 2024 | 854.57M | 33.16% |
| Dec 29, 2023 | 641.78M | -37.23% |
| Dec 30, 2022 | 1.02B | -70.64% |
| Dec 31, 2021 | 3.48B | -47.33% |
| Dec 31, 2020 | 6.61B | 99.43% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 239.33B |
| Siemens Aktiengesellschaft | 169.28B |
| Allianz SE | 136.62B |
| Deutsche Telekom AG | 129.38B |
| Siemens Energy AG | 92.82B |
| Rheinmetall AG | 73.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.45B |
| Deutsche Bank Aktiengesellschaft | 56.97B |